<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Peroxisome proliferator-activated receptor (PPAR) alpha, a transcription factor of the nuclear receptor superfamily, regulates fatty acid oxidation </plain></SENT>
<SENT sid="1" pm="."><plain>We evaluated the association of single nucleotide polymorphisms (SNPs) of the PPAR-alpha gene (PPARA) with the conversion from <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> to type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in 767 subjects of the STOP-<z:mp ids='MP_0002057'>NIDDM</z:mp> trial in order to investigate the effect of <z:chebi fb="0" ids="2376">acarbose</z:chebi> in comparison with placebo on the prevention of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In the placebo group, the G (162V) allele of rs1800206 increased the risk for <z:mp ids='MP_0002055'>diabetes</z:mp> by 1.9-fold (95% CI 1.05-3.58) and was associated with elevated levels of plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and insulin </plain></SENT>
<SENT sid="3" pm="."><plain>The effect of this allele on the risk of <z:mp ids='MP_0002055'>diabetes</z:mp> in the placebo group was enhanced by the simultaneous presence of the risk alleles of the PPAR-gamma2, PPAR-gamma coactivator 1alpha, and hepatic nuclear factor 4alpha genes (odds ratios 2.2, 2.5, and 3.4, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>In the <z:chebi fb="0" ids="2376">acarbose</z:chebi> group, subjects carrying the minor G allele of rs4253776 and the CC genotype of rs4253778 of PPARA had a 1.7- and 2.7-fold increased risk for <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Our data indicate that SNPs of PPARA increase the risk of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> alone and in combination with the SNPs of other genes acting closely with PPAR-alpha </plain></SENT>
</text></document>